►Home ►Site Index
TOPIGEN TO PARTICIPATE IN BMO AND RBC HEALTHCARE CONFERENCES
TOPIGEN PHARMACEUTICALS BEGINS PATIENT DOSING IN PHASE 2 TRIAL OF TPI 1020 IN COPD
TOPIGEN PHARMACEUTICALS TO ADVANCE TPI 1020 INTO PHASE 2 DEVELOPMENT FOR COPD
TOPIGEN SECURES C$26M IN SERIES C VENTURE FINANCING
TOPIGEN PRESENTS NEW DATA ON ITS PHASE II ASTHMA PRODUCT, TPI ASM8 AT THE AMERICAN THORATIC SOCIETY ANNUAL MEETING
TOPIGEN TO PROVIDE UPDATES ON NOVEL TREATMENTS FOR RESPIRATORY DISEASES AT CONFERENCES IN SCOTLAND AND CANADA
TOPIGEN TO PRESENT UPDATES ON CLINICAL PROGRAMS AT BIOFINANCE 2007 AND 2007 BIO INTERNATIONAL CONVENTION
TOPIGEN EXPANDS EXECUTIVE TEAM WITH SENIOR BUSINESS DEVELOPMENT AND PHARMACEUTICAL DEVELOPMENT APPOINTMENTS
TOPIGEN AND NOVAGALI ENTER INTO STRATEGIC COLLABORATION FOR ALLERGIC OCULAR DISEASES AND ALLERGIC RHINITIS
TOPIGEN INITIATES EXPANDED PHASE II TRIAL OF INHALED TPI ASM8 IN PATIENTS WITH ASTHMA
2008 Archives 2006 Archives 2005